Ascendis Pharma A/S
ASND
9 insider filings · Latest: Sep 8, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Sep 8, 2026 | Sep 9 9:04 PM | Mads BodenhoffSVP & PAO | Sale | 3,000 | $270.19 | $810.6K | 0(D) | View → |
| Sep 8, 2026 | Sep 8 8:16 PM | Bodenhoff Mads | Proposed Sale | 3,000 | $270.19 | $810.6K | — | View → |
| Sep 2, 2026 | Sep 3 8:09 PM | Lars HoltugDirector | Sale | 236 | $264.13 | $62.3K | 4,000(D) | View → |
| Sep 2, 2026 | Sep 2 4:52 PM | HOLTUG LARS | Proposed Sale | 236 | $264.13 | $62.3K | — | View → |
| Aug 14, 2026 | Aug 19 1:02 AM | Jean Jacques BienaimeDirector | Purchase | 2,000 | $246.33 | $492.7K | 2,900(D) | View → |
| Jun 2, 2026 | Jun 2 8:25 PM | Scott Thomas SmithEVP & Chief Financial Officer | Purchase | 100 | $219.00 | $21.9K | 4,367(D) | View → |
| May 29, 2026 | Jun 1 8:11 PM | Jean Jacques BienaimeDirector | Purchase | 500 | $223.12 | $111.6K | 900(D) | View → |
| May 29, 2026 | Jun 1 8:10 PM | Scott Thomas SmithEVP & Chief Financial Officer | Purchase | 250 | $223.32 | $55.8K | 4,267(D) | View → |
| May 26, 2026 | May 27 8:05 PM | Jean Jacques BienaimeDirector | Purchase | 400 | $237.80 | $95.1K | 400(D) | View → |
| May 11, 2026 | May 12 8:08 PM | Flemming Steen JensenEVP & Product Supply and Quality | Sale | 19,460 | $238.49 | $4.6M | 0(D) | View → |
| May 11, 2026 | May 11 7:36 PM | JENSEN FLEMMING STEEN | Proposed Sale | 19,460 | $238.49 | $4.6M | — | View → |
| Mar 9, 2026 | Mar 9 9:30 PM | SINGEL STINA | Proposed Sale | 3,782 | $240.00 | $907.7K | — | View → |
| Mar 6, 2026 | Mar 6 9:21 PM | Bodenhoff Mads | Proposed Sale | 10,000 | $237.53 | $2.4M | — | View → |
| Mar 5, 2026 | Mar 6 1:44 PM | SMITH SCOTT THOMAS | Proposed Sale | 10,000 | $240.00 | $2.4M | — | View → |
| Mar 5, 2026 | Mar 5 10:20 PM | Shu Aimee | Proposed Sale | 5,583 | $235.81 | $1.3M | — | View → |
| Mar 5, 2026 | Mar 5 10:07 PM | SMITH SCOTT THOMAS | Proposed Sale | 10,000 | $240.00 | $2.4M | — | View → |
| Mar 5, 2026 | Mar 5 10:04 PM | Jan Moller Mikkelsen | Proposed Sale | 94,000 | $241.38 | $22.7M | — | View → |
| Mar 4, 2026 | Mar 4 9:58 PM | Morrison Lisa | Proposed Sale | 10,105 | $236.34 | $2.4M | — | View → |
| Mar 4, 2026 | Mar 4 3:54 PM | Shu Aimee | Proposed Sale | 7,290 | $239.22 | $1.7M | — | View → |
| Mar 2, 2026 | Mar 2 10:01 PM | Fairey William | Proposed Sale | 1,800 | $242.09 | $435.8K | — | View → |
Page 1 of 5
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Apr 14, 2026 | Sep 28 8:08 PM | Jean Jacques BienaimeDirector | Grant/Award | 9,160 | $249.84 | 9,160(D) | View → |
| Apr 14, 2026 | Sep 28 8:08 PM | Jean Jacques BienaimeDirector | Disposition | 9,160 | $172.35 | 0(D) | View → |
| Sep 8, 2026 | Sep 9 9:04 PM | Mads BodenhoffSVP & PAO | Option Exercise | 3,000 | $110.00 | 687(D) | View → |